Targeted cancer therapy often results in predictable mutations that lead to drug resistance. Precision immuno-oncology is our approach to treating cancer by preventing clinical resistance from developing. Our srRNAs educate the immune system to recognize and remove common mutations, extending the time that people with cancer may benefit from a targeted therapy.LEARN MORE ABOUT PRECISION IMMUNO-ONCOLOGy
srRNA technology allows us to rapidly develop effective, low-dose vaccines for complex infectious disease targets.LEARN MORE ABOUT COMPLEX INFECTIOUS DISEASe
Autoimmune diseases are often driven by the overexpression of inflammatory molecules. Current approaches struggle to quell this over-activity. Our pipeline includes srRNA-encoded molecules that halt the pathways that drive inflammatory and autoimmune diseases by targeting downstream mediators of the inflammasome.